Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Portugal

INFARMED regulates medicines and runs SiNATS health-technology assessment, price and reimbursement processes. National decisions and contracts are followed by NHS hospital formulary, procurement and supply execution.

EC/EMA or INFARMED
MAH/representative / INFARMED
DATS/CATS
DATS/CATS / applicant
INFARMED / health ministry authority / MAH
8 decision nodes16 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it